Yasuhiro Oki Selected Research

Yasuhiro Oki Research Topics

Disease

29	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 02/2007
29	Lymphoma (Lymphomas) 01/2019 - 08/2005
24	Neoplasms (Cancer) 11/2023 - 08/2004
20	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 07/2008
15	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2018 - 08/2004
10	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 07/2008
10	T-Cell Lymphoma (Lymphoma, T Cell) 08/2020 - 05/2012
8	Neutropenia 11/2018 - 01/2008
7	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2021 - 12/2009
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2012 - 02/2006
5	Thrombocytopenia (Thrombopenia) 01/2018 - 01/2008
5	Disease Progression 01/2016 - 08/2005
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2019 - 05/2012
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019 - 12/2009
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 11/2009
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 11/2014
3	Hematologic Neoplasms (Hematological Malignancy) 11/2018 - 02/2007
3	Diarrhea 11/2018 - 12/2009
3	Anemia 01/2018 - 12/2013
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2016 - 01/2007
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2007 - 08/2004
2	Fatigue 08/2020 - 12/2013
2	Melanoma (Melanoma, Malignant) 01/2019 - 08/2004
2	Exanthema (Rash) 11/2018 - 01/2018
2	Febrile Neutropenia 01/2018 - 12/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 01/2010
2	Radiation Pneumonitis 12/2016 - 05/2015
2	Infections 01/2016 - 12/2013
2	Dyspnea (Shortness of Breath) 12/2014 - 12/2013
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 08/2020
1	Residual Neoplasm 01/2020
1	Mycosis Fungoides 09/2018

Drug/Important Bio-Agent (IBA)

31	Rituximab (Mabthera)FDA Link 11/2023 - 01/2008
17	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 05/2012
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 01/2008
11	Vincristine (Oncovin)FDA LinkGeneric 11/2023 - 12/2013
9	Prednisone (Sone)FDA LinkGeneric 11/2023 - 12/2013
8	Brentuximab VedotinIBA 01/2022 - 05/2012
7	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 05/2012
7	Decitabine FDA Link 10/2012 - 05/2006
6	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 05/2012
6	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 01/2008
5	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 05/2012
5	Methotrexate (Mexate)FDA LinkGeneric 10/2018 - 12/2013
5	Gemcitabine FDA Link 01/2018 - 02/2008
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 01/2008
4	ibrutinibIBA 01/2023 - 08/2014
4	Lenalidomide (CC 5013)FDA Link 01/2023 - 11/2014
4	Histone Deacetylases (Histone Deacetylase)IBA 10/2021 - 01/2013
4	Histone Deacetylase InhibitorsIBA 02/2021 - 12/2011
4	Vorinostat FDA Link 11/2020 - 07/2013
4	Transaminases (Aminotransferases)IBA 08/2020 - 01/2008
4	EnzymesIBA 11/2018 - 01/2010
4	Melphalan (Alkeran)FDA LinkGeneric 01/2018 - 12/2009
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 02/2007
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2015
3	Immunoconjugates (Immunoconjugate)IBA 02/2019 - 05/2014
3	duvelisibIBA 11/2018 - 01/2018
3	Bortezomib (Velcade)FDA Link 01/2018 - 02/2016
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 02/2016
3	Ifosfamide FDA LinkGeneric 01/2018 - 02/2016
3	PanobinostatIBA 01/2018 - 06/2011
3	AnthracyclinesIBA 03/2016 - 01/2015
3	MethyltransferasesIBA 01/2016 - 02/2007
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2015
2	Everolimus FDA Link 11/2020 - 12/2013
2	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2020 - 01/2018
2	romidepsin (FK228)FDA Link 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2019
2	Busulfan (Busulfex)FDA Link 01/2018 - 11/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 01/2018
2	Alanine Transaminase (SGPT)IBA 01/2018 - 01/2018
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018 - 08/2014
2	CUDC-907IBA 11/2017 - 01/2016
2	fludarabineIBA 01/2017 - 01/2016
2	Azacitidine (5 Azacytidine)FDA Link 01/2016 - 05/2006
2	liposomal doxorubicin (Doxil)FDA Link 11/2015 - 03/2015
2	Peptides (Polypeptides)IBA 01/2007 - 08/2004
2	VaccinesIBA 01/2007 - 08/2004
1	Circulating Tumor DNAIBA 11/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2021
1	fimepinostatIBA 10/2021
1	belinostatIBA 02/2021
1	MTOR InhibitorsIBA 11/2020
1	Sirolimus (Rapamycin)FDA Link 11/2020
1	tenalisibIBA 08/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	MLN 8237IBA 01/2020
1	B7-H1 AntigenIBA 01/2019
1	pembrolizumabIBA 01/2019
1	ParaffinIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2018

Therapy/Procedure

30	Therapeutics 11/2020 - 01/2007
27	Drug Therapy (Chemotherapy) 07/2018 - 02/2006
21	Radiotherapy 05/2019 - 06/2014
7	Stem Cell Transplantation 01/2018 - 12/2011
3	Induction Chemotherapy 10/2018 - 12/2009
2	Hematopoietic Stem Cell Transplantation 05/2015 - 12/2011